RxDoctor Payments Data

Daniel Kim

Cardiovascular Disease · San Diego, CANPI 1629575147

Payments from drug & device makers

What this record shows

This record is dominated by grants: $14,063 of the $18,441 with a category attached, or 76.3%. Boston Scientific accounts for 60.4% of it on its own, with 20 other manufacturers making up the rest. 2025 is the largest year on record at $10,184, more than ten times the $517 reported in 2022.

$18,441in general payments, 2019–2025

Across 49 payments — averaging $376.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$11K
  • Medtronic$3K
  • Abiomed$1K
  • Amgen$474
  • Abbott$432
  • Irhythm Technologies, Inc.$299
  • plus $2K from 15 others

What the payments were for

  • Grants$14,06376%
  • Travel & lodging$6253%
  • Food & beverage$3,14417%
  • Education$6093%

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$18,441 in reported general payments places this provider in the 85th percentile of 2,184 cardiovascular disease providers in California.

See all cardiovascular disease providers in California →

Other cardiovascular disease in San Diego

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →